Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
PRICE MICHAEL DENNIS
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/13/2020
4
Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2020
4
PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.
Txns:
Granted 50,000 shares @ $0
Granted 300,000 options to buy @ $14.78, valued at $4.4M
05/19/2020
3
PRICE MICHAEL DENNIS (CFO) has filed a Form 3 on AKCEA THERAPEUTICS, INC.
09/26/2019
4
PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
Paid exercise price by delivering 3,926 shares @ $0.76, valued at $3k
11/28/2018
4
PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
Paid exercise price by delivering 1,963 shares @ $0.92, valued at $1.8k
12/06/2017
3
PRICE MICHAEL DENNIS (CFO) has filed a Form 3 on NOVELION THERAPEUTICS INC.
08/27/2009
4
Form 4 - Statement of changes in beneficial ownership of securities
08/21/2009
4
PRICE MICHAEL DENNIS (VP and CFO) has filed a Form 4 on NOVEN PHARMACEUTICALS INC
11/25/2008
4
Form 4 -- Statement of changes in beneficial ownership of securities
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy